Annual revenue of top 10 big pharma companies

According to market research, the worldwide pharmaceutical market was worth nearly $1.3 trillion in 20191 and the top 10 pharma companies accounted for around a third of sales ($392.5 billion).

Below is a graph of this year’s top 10 pharma companies, ranked by pharmaceutical revenue, along with a table with more on their performance compared to last year. Pfizer (NYSE: PFE) maintained pole position with full year revenues of $51.75 billion, but sales declined by 4% year-on-year as key drug patent expiries and Ibrance (palbociclib) and Lyrica (pregabalin) underperformed1.

Swiss pharma giants Roche2 (ROG: SIX) and Novartis3 (NOVN: VX) held onto second and third place, generating pharma revenues of 48.52 billion Swiss francs ($50.24 billion) and $47.45 billion, respectively.